Status:

COMPLETED

Training About Sudden Infant Death Syndrome

Lead Sponsor:

Ondokuz Mayıs University

Conditions:

Sudden Infant Death

Eligibility:

FEMALE

20-40 years

Phase:

NA

Brief Summary

Sudden infant death syndrome, which constitutes a significant proportion of all infant deaths, is associated with various preventable risk factors. The study aims examine effects of training provided ...

Detailed Description

Sudden infant death syndrome, which constitutes a significant proportion of all infant deaths, is associated with various preventable risk factors. To examine effects of training provided to pregnant ...

Eligibility Criteria

Inclusion

  • Pregnant women who were in the 38th week of their pregnancy and older,
  • Lived a healthy pregnancy,
  • Had no communication problems,
  • Can speak and understand Turkish,
  • Agreed to participate in the study were included.

Exclusion

  • Pregnant women who were earlier than 38 weeks pregnant,
  • Had difficulty in communicating,
  • Were illiterate and unable to speak Turkish,
  • Who filled out the forms incompletely were not included.

Key Trial Info

Start Date :

April 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 30 2024

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT06922682

Start Date

April 1 2024

End Date

July 30 2024

Last Update

April 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Samsun Gynecology and Children's Diseases Hospital in Turkey

Samsun, Black Sea Zone, Turkey (Türkiye), 55100